European Archives - Page 2 of 1541 - European Medical Journal

GLP-1 injection a breakfast table next to a coffee and some cereal

Study finds small hair loss risk with GLP-1 therapies

It found that patients taking weight loss drugs had a modestly higher risk of developing non-scarring alopecia.

Hospitalisation Shifts in Inflammatory Rheumatic Diseases - EMJ

Hospital Data Reveals Shifting Face of Rheumatic Disease Care

A nationwide German analysis found that hospitalisation patterns in inflammatory rheumatic diseases have shifted substantially since 2010.

Photosensitive Disease Scoring Improved with UV Weighting - EMJ

UV-Weighted Scoring Improves Photosensitive Disease Assessment

Researchers have developed a UV-weighted scoring system that could improve the assessment of photosensitive skin diseases by reducing body surface area-related bias.

Composite Inflammatory Markers Predict Stroke Recurrence Risk

Composite Inflammatory Markers Predict Stroke Recurrence Risk

A large cohort study found that composite inflammatory markers, particularly SIRI, can predict stroke recurrence and other adverse outcomes.

Dabrafenib Plus Trametinib in Thyroid Cancer - EMJ

Targeted Therapy Improved Outcomes in Advanced Thyroid Cancer

A Phase III trial found that dabrafenib plus trametinib significantly improved progression free survival and response rates in previously treated patients with radioactive iodine refractory BRAFV600E positive differentiated thyroid cancer.

Hepatitis C Elimination May Prevent Deaths and Cut Costs - EMJ

Hepatitis C Elimination Initiative Could Prevent Deaths and Cut Costs

A proposed hepatitis C elimination initiative in the US was projected to prevent thousands of deaths, reduce HCV cases and save billions in healthcare spending.

NHS Lung Cancer Screening Scales Imaging Nationwide - EMJ

NHS Lung Cancer Screening Model Could Guide Future Imaging Programmes

A cloud-native NHS lung cancer screening model enabled more than 1 million LDCT scans to be reported and could help shape future imaging-based screening programmes.

Improved Outcomes in Lower-Risk MDS

This lower-risk myelodysplastic syndromes symposium provided an overview of emerging data from pivotal trials and real-world evidence…

EAN 2026 Interview: Elena Moro

During my presidency, together with my Board, I built upon the work carried out by my two predecessors, Claudio Bassetti, University of Bern…

ICNMD 2026 Interview: Marianne de Visser

Marianne de Visser: Adult Neurologist and Emeritus Professor of Neuromuscular Diseases, Amsterdam University Medical Center…